PTN — PALATIN TECHNOLOGIES INC

—
Nasdaq · Health Care · Pharmaceuticals · CIK 911216 ·
Last close
$5.36
Market Cap
$9.55M
52W High
$31.00
52W Low
$4.51
ADV30
38,385
Next earnings
—

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Jun 2026 300,770 — -4,419,799 -4,358,581 8,523,854 7,492,014 1,837,389
Mar 2026 3,920,675 — -1,580,994 -1,432,987 13,225,337 10,159,494 2,633,459
Dec 2025 116,036 — -7,328,548 -7,263,861 17,927,728 14,476,162 6,461,709
Sep 2025 8,847,550 — 4,661,053 4,677,534 8,614,660 1,273,083 8,218,261

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-14,932,332
Investing CF
$591,517
Financing CF
$21,993,063
CapEx
$-38,483
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-8.10
As of
2026-10-05

Balance + Analyst (yfinance extras)

Retained Earnings
$-463,093,213
Inventory
—
Receivables
$2,167,215
ST Investments
—
EBIT TTM
$-6,241,857
Pretax Income TTM
$-6,249,112
Interest Exp TTM
$7,255
Analysts
3

Yahoo Snapshot (yfinance, live)

Total Revenue
$13,185,031
EBITDA
$-8,605,609
Free Cash Flow
$-10,665,235
Enterprise Value
$9,347,900
Total Cash
$7,492,014
Total Debt
$223,679
Shares Out
1,780,939
Trailing EPS
$-2.96
Book Value
$5.96
ROE
-877.5%
ROA
-91.9%
Div Yield
0.00%

Annual Trend (SEC EDGAR, last 5y)

Revenues vs Net Income (last 5y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Jun 2026 13,185,031 -8,668,288 -8,377,895 8,523,854 1,837,389 6,686,465 -13,533,270
Jun 2025 0 -22,707,839 -17,307,349 3,266,954 8,043,999 -4,777,045 -21,306,637
Jun 2024 4,490,090 -30,277,965 -29,736,113 10,742,266 10,853,763 -111,497 -31,461,441
Jun 2023 4,853,678 -33,486,205 -24,036,741 17,939,440 19,919,311 -1,979,871 -29,271,346
Jun 2022 — — — — — — —

TTM Snapshot

Revenues TTM
$13,185,031
NetIncome TTM
$-8,377,895
OpCashFlow TTM
—
Assets (Latest)
$13,225,337
Forward EPS
$-1.85

Peers — same industry

TickerNameMarket CapLastDaily %
PBM PSYENCE BIOMEDICAL LTD. $9.57M $2.51 —
BIVI BIOVIE INC. $9.61M $1.00 —
RADX Radiopharm Theranostics Ltd $9.70M $0.67 —
GDTC CytoMed Therapeutics Ltd $9.27M $0.78 —
CLRB Cellectar Biosciences, Inc. $9.24M $0.92 —

News headlines (Yahoo Finance, 1h cache)

Palatin Technologies, Inc. Q1 2027 Earnings Call Summary
2026-11-17 21:51 · Yahoo
Palatin Reports Fiscal First Quarter 2027 Financial Results and Provides Business Update
2026-11-17 12:30 · Yahoo
Palatin Technologies Presents Compelling Preclinical Data on Next-Generation MC4R-Selective Peptide Agonists at ObesityWeek® 2026
2026-11-16 12:30 · Yahoo
Palatin to Report First Quarter Fiscal Year 2027 Results
2026-11-13 12:30 · Yahoo
Palatin Technologies, Inc. Q4 2026 Earnings Call Summary
2026-09-29 12:30 · Yahoo
Palatin Reports Fiscal Year 2026 Financial Results and Provides Business Update
2026-09-28 11:30 · Yahoo
StreetWatch: A $2.9 Billion Takeover Put a Spotlight on Relentless Hunger. Palatin Technologies Is Developing the Next Generation of the Drug That Seeks to Treat It
2026-08-06 13:40 · Yahoo
Transcript: Palatin Techs Q3 2026 Earnings Conference Call
2026-05-13 15:31 · Yahoo
Palatin Reports Fiscal Third Quarter 2026 Financial Results and Provides Business Update
2026-05-13 11:30 · Yahoo
Palatin Technologies, Inc. Q3 2026 Earnings Call Summary
2026-05-14 12:30 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.